Literature DB >> 20182586

Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.

Wei Cui1, Stephen L Chen, Ke-Qin Hu.   

Abstract

Developing a quantifiable in vitro model of steatosis is critical in understanding the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and searchingfor effective therapies. Using an ORO-based colorimetric measurement, we developed a convenient assay to qualify the degree of OA-induced steatosis in HepG2 cells. We demonstrated that in the absence of exogenous inflammatory mediators, OA-induced steatosis was associated with increased production and secretion of tumor necrosis factor alpha and decreased expression of peroxisome proliferators-activated receptor alpha in HepG2 cells. OA-induced steatosis was also associated with increased lipid peroxidation, apoptosis, but decreased proliferation in these cells. The increased lipid peroxidation was related to decreased SOD-1, a free radical scavenger enzyme; while increased apoptosis was related to increased active caspase-9. The decreased proliferation mediated by OA-induced steatosis was associated with increased production of p27 with unchanged alanine transaminase (ALT) level in the culture medium, indicating OA-induced steatosis alters cell cycle progression without direct toxicity to these cells. In conclusion, the present study developed a colorimetric assay that accurately quantifies OA-induced steatosis in HepG2 cells. In the absence of exogenous inflammatory mediators, OA-induced steatosis results in a series of pathophysilogical changes in HepG2 cells, indicating direct pathogenic roles of hepatocytes in NAFLD.

Entities:  

Keywords:  Steatosis; apoptosis; cell proliferation; lipid peroxidation; peroxisome proliferators-activated receptor α; tumor necrosis factor α

Year:  2010        PMID: 20182586      PMCID: PMC2826826     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  43 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  Thiazolidinediones.

Authors:  Hannele Yki-Järvinen
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

3.  A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.

Authors:  Gianluca Svegliati-Baroni; Cinzia Candelaresi; Stefania Saccomanno; Gianna Ferretti; Tiziana Bachetti; Marco Marzioni; Samuele De Minicis; Liliana Nobili; Renata Salzano; Alessia Omenetti; Deborah Pacetti; Soeren Sigmund; Antonio Benedetti; Alessandro Casini
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

4.  Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice.

Authors:  M Yin; M D Wheeler; H Kono; B U Bradford; R M Gallucci; M I Luster; R G Thurman
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

5.  Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis.

Authors:  Rita M Ramalho; Helena Cortez-Pinto; Rui E Castro; Susana Solá; Adília Costa; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 2.566

6.  Clinical significance of soluble TNF receptor in Japanese patients with non-alcoholic steatohepatitis.

Authors:  Katsutoshi Tokushige; Etsuko Hashimoto; Noriko Tsuchiya; Hiroyuki Kaneda; Makiko Taniai; Keiko Shiratori
Journal:  Alcohol Clin Exp Res       Date:  2005-12       Impact factor: 3.455

Review 7.  Mechanisms of disease progression in nonalcoholic fatty liver disease.

Authors:  Janice Jou; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

8.  Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.

Authors:  Paulo S Ribeiro; Helena Cortez-Pinto; Susana Solá; Rui E Castro; Rita M Ramalho; Amélia Baptista; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

9.  Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.

Authors:  Ke-Qin Hu; Chang-Hong Yu; Yoshimitsu Mineyama; John D McCracken; Donald J Hillebrand; Mateen Hasan
Journal:  Int J Oncol       Date:  2003-04       Impact factor: 5.650

10.  A Three Stage Integrative Pathway Search (TIPS) framework to identify toxicity relevant genes and pathways.

Authors:  Zheng Li; Shireesh Srivastava; Sheenu Mittal; Xuerui Yang; Lufang Sheng; Christina Chan
Journal:  BMC Bioinformatics       Date:  2007-06-14       Impact factor: 3.169

View more
  60 in total

Review 1.  Drug-induced steatohepatitis.

Authors:  Ajit Dash; Robert A Figler; Arun J Sanyal; Brian R Wamhoff
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-10-27       Impact factor: 4.481

Review 2.  Lipid lowering effects of iodothyronines: In vivo and in vitro studies on rat liver.

Authors:  Laura Vergani
Journal:  World J Hepatol       Date:  2014-04-27

3.  Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.

Authors:  Guoxiang Xie; Xiaoning Wang; Fengjie Huang; Aihua Zhao; Wenlian Chen; Jingyu Yan; Yunjing Zhang; Sha Lei; Kun Ge; Xiaojiao Zheng; Jiajian Liu; Mingming Su; Ping Liu; Wei Jia
Journal:  Int J Cancer       Date:  2016-06-17       Impact factor: 7.396

4.  The effect of miRNA-122 in regulating fat deposition in a cell line model.

Authors:  Yu-Qiang Nie; Jie Cao; Yong-Jian Zhou; Xia Liang; Yan-Lei Du; Yu-Jui Yvonne Wan; Yu-Yuan Li
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

5.  Overexpression of variant PNPLA3 gene at I148M position causes malignant transformation of hepatocytes via IL-6-JAK2/STAT3 pathway in low dose free fatty acid exposure: a laboratory investigation in vitro and in vivo.

Authors:  Zhengtao Liu; Tianchi Chen; Xiaoxiao Lu; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

6.  Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease.

Authors:  Mohammad J Alkhatatbeh; Lisa F Lincz; Rick F Thorne
Journal:  Exp Ther Med       Date:  2016-02-10       Impact factor: 2.447

7.  Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model.

Authors:  Xiuli Li; Rong Wang; Na Zhou; Xiaohui Wang; Qingyan Liu; Yuqin Bai; Yin Bai; Zhijie Liu; Huiming Yang; Jihong Zou; Hongxia Wang; Tiewei Shi
Journal:  Biomed Rep       Date:  2012-10-22

8.  Effects of high-fat diet on liver injury after small bowel resection.

Authors:  Emily J Onufer; Yong-Hyun Han; Rafael S Czepielewski; Cathleen M Courtney; Stephanie Sutton; Gwendalyn J Randolph; Brad W Warner
Journal:  J Pediatr Surg       Date:  2020-02-28       Impact factor: 2.545

Review 9.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

10.  Detection of a lipid peroxidation-induced DNA adduct across liver disease stages.

Authors:  Heidi Coia; Ning Ma; Aiwu Ruth He; Bhaskar Kallakury; Deborah L Berry; Eva Permaul; Kepher H Makambi; Ying Fu; Fung-Lung Chung
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.